Meet One of Our
Health Board Advisors Expert

Gary Goldman, DDS, MD, MBA

Bio:

Dr. Gary Goldman. He holds three degrees—DDS, MD, and MBA—and serves as Founding Partner of Global Health Impact Fund and CEO of Global Health Impact Network. Dr Gary built a physician-founded venture capital fund focused on digital health, creating a community where clinicians connect to healthtech investment.

A Trusted Voice:

Top Keynote Talk Topics:

  • The Future of
    Depression Care:
    What Weʼre Learning
    From 900+ DBS
    Surgeries A talk that
    breaks down how
    deep brain stimulation
    helps people with severe depression, what the newest NIH-funded research is showing, and how imaging helps predict who will benefit.

  • The Future of Depression Care: What Weʼre Learning From 900+ DBS Surgeries A talk that breaks down how deep brain stimulation helps people with severe depression, what the newest NIH-funded research is showing, and how imaging helps predict who will benefit.

  • When Treatment Fails: New Hope for Patients With Tremor, Parkinsonʼs, and Depression A practical look at what happens when medications stop working and how DBS and focused ultrasound offer strong, lasting results — with real data and clear explanations for clinicians and leaders.

  • Why Advanced Brain Treatments Are Underused — And How We Can Fix It A keynote for health systems, policymakers, and investors about the barriers that keep patients from life-changing treatments, how much this costs the system, and what solutions can improve access.

  • Building Better Brain Implants: What Doctors, Industry, and Patients Really Need Based on Dr. Fenoyʼs experience working with medical device companies and inventing new tools. Covers what makes technology adoptable, what the field is missing, and how to design devices people will actually use.

  • Using Brain Imaging to Guide Care: How fMRI and DTI Are Changing Neurosurgery A simple explanation of how imaging shows brain networks changing over time — and how this helps predict outcomes, improve device placement, and personalize care for movement and mood disorders.

Top Keynote Talk Topics:

  • The Evolution of Vaccine Policy: What the Public Was Never Told

    How vaccine recommendations evolved over decades.
    What early safety signals revealed.

    Where policy and science diverged.

    Key points: Historical development of vaccine schedules, Early debates around safety monitoring, Why transparency matters in public health policy

  • When Science Meets Politics: The Hidden Pressures in Public Health

    How research findings can be shaped by institutional pressure.

    Key points: The tension between scientific discovery and policy agendas, Challenges researchers face when findings contradict prevailing narratives, The importance of independent analysis and peer review.

  • Vaccine Safety Research: Lessons from Decades of Data

    A research-driven look at vaccine safety monitoring systems.

    Key points: Epidemiological research methods in vaccine safety, Interpreting population-level data, Why continuous safety surveillance is essential.

  • Public Trust in Medicine: How Transparency Builds Confidence

    Why public confidence depends on open dialogue and honest science.

    Key points: The erosion of trust in health institutions, What transparency actually looks like in public health, How clinicians and scientists can rebuild credibility.

  • Informed Consent in Modern Medicine

    What true informed consent means in preventive medicine.

    Key points: Ethical foundations of medical consent, Risk communication with patients, The role of physicians in helping patients make informed decisions.

Top Keynote Talk Topics:

  • The Evolution of Vaccine Policy: What the Public Was Never Told

    How vaccine recommendations evolved over decades.
    What early safety signals revealed.

    Where policy and science diverged.

    Key points: Historical development of vaccine schedules, Early debates around safety monitoring, Why transparency matters in public health policy

  • When Science Meets Politics: The Hidden Pressures in Public Health

    How research findings can be shaped by institutional pressure.

    Key points: The tension between scientific discovery and policy agendas, Challenges researchers face when findings contradict prevailing narratives, The importance of independent analysis and peer review.

  • Vaccine Safety Research: Lessons from Decades of Data

    A research-driven look at vaccine safety monitoring systems.

    Key points: Epidemiological research methods in vaccine safety, Interpreting population-level data, Why continuous safety surveillance is essential.

  • Public Trust in Medicine: How Transparency Builds Confidence

    Why public confidence depends on open dialogue and honest science.

    Key points: The erosion of trust in health institutions, What transparency actually looks like in public health, How clinicians and scientists can rebuild credibility.

  • Informed Consent in Modern Medicine

    What true informed consent means in preventive medicine.

    Key points: Ethical foundations of medical consent, Risk communication with patients, The role of physicians in helping patients make informed decisions.

Top Interview Questions:

  1. What originally drew you into studying vaccine safety and public health policy, and how did that path shape the focus of your research over the years?

  2. When you began analyzing vaccine safety data, what findings or patterns surprised you the most, and how did they influence your perspective on public health policy?

  3. You have spoken about the tension that can arise between scientific findings and institutional narratives. How should researchers navigate situations where their data challenges established positions?

  1. Public trust in healthcare institutions has become a major topic globally. In your view, what factors most influence whether the public trusts medical guidance and research?

  2. When people encounter conflicting interpretations of vaccine safety studies, how should they approach evaluating the evidence and understanding the broader scientific conversation?

  3. Looking ahead, what improvements would you like to see in how vaccine safety research, transparency, and communication are handled by public health institutions?

Connect With Dr. Gary